Axxcess Wealth Management LLC Buys 9,342 Shares of Astera Labs, Inc. $ALAB

Axxcess Wealth Management LLC increased its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 219.9% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 13,590 shares of the company’s stock after acquiring an additional 9,342 shares during the quarter. Axxcess Wealth Management LLC’s holdings in Astera Labs were worth $2,661,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Great Valley Advisor Group Inc. boosted its holdings in Astera Labs by 2.2% during the 2nd quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock worth $372,000 after acquiring an additional 90 shares during the last quarter. Rye Brook Capital LLC boosted its holdings in Astera Labs by 1.1% during the third quarter. Rye Brook Capital LLC now owns 9,200 shares of the company’s stock worth $1,801,000 after purchasing an additional 100 shares during the last quarter. Assetmark Inc. boosted its holdings in Astera Labs by 374.1% during the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after purchasing an additional 101 shares during the last quarter. First Horizon Advisors Inc. grew its position in Astera Labs by 12.4% in the 2nd quarter. First Horizon Advisors Inc. now owns 982 shares of the company’s stock worth $89,000 after purchasing an additional 108 shares in the last quarter. Finally, SlateStone Wealth LLC increased its stake in Astera Labs by 1.3% in the 3rd quarter. SlateStone Wealth LLC now owns 12,744 shares of the company’s stock valued at $2,495,000 after buying an additional 160 shares during the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on ALAB. BNP Paribas Exane initiated coverage on Astera Labs in a research note on Thursday, November 20th. They issued an “outperform” rating on the stock. Roth Mkm boosted their price objective on Astera Labs from $200.00 to $225.00 and gave the stock a “buy” rating in a research report on Wednesday, November 5th. Jefferies Financial Group restated a “buy” rating on shares of Astera Labs in a research note on Wednesday, December 3rd. JPMorgan Chase & Co. raised their target price on Astera Labs from $180.00 to $215.00 and gave the company an “overweight” rating in a research report on Wednesday, November 5th. Finally, Royal Bank Of Canada started coverage on shares of Astera Labs in a report on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 price target on the stock. Fourteen analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $192.89.

Astera Labs Stock Performance

NASDAQ:ALAB opened at $132.62 on Friday. The business’s fifty day moving average is $160.78 and its 200 day moving average is $174.12. The firm has a market cap of $22.40 billion, a price-to-earnings ratio of 108.70, a PEG ratio of 2.55 and a beta of 1.50. Astera Labs, Inc. has a 52-week low of $47.13 and a 52-week high of $262.90.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, beating analysts’ consensus estimates of $0.51 by $0.07. Astera Labs had a return on equity of 16.87% and a net margin of 25.70%.The business had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. During the same quarter in the previous year, the firm earned $0.37 EPS. The company’s quarterly revenue was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Equities analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Seeking Alpha highlights that revenue more than doubled year‑over‑year and free cash flow margins remain strong (above 30%), with a cash balance ~ $1.19B and no debt — supporting financial flexibility and giving investors confidence in the business. The Great Astera Labs Reset
• Positive Sentiment: Analyst commentary (Zacks) points to surging AI connectivity demand and Astera’s expansion of NVLink/Scorpio product lines, which could drive a much larger TAM (analysts mention a potential 10x market to ~$25B over five years) — a growth narrative that tends to support higher multiples. ALAB Rides on Strong Connectivity Demand
• Neutral Sentiment: Reported short interest data is essentially zero / unchanged (short‑interest ratio ~0 days) — little visible short pressure to amplify moves in either direction at present.
• Negative Sentiment: CEO Jitendra Mohan sold 94,971 shares at ~$123.81 (reported Feb 17), a ~6.14% reduction in his holdings — a sizable insider sale that can weigh on sentiment. CEO Form 4
• Negative Sentiment: COO Sanjay Gajendra sold 94,971 shares at ~$123.81 (reported Feb 17), a ~5.84% cut to his stake — adds to the cluster of large insider sales. COO Form 4
• Negative Sentiment: CFO Michael Truett Tate sold 12,001 shares at ~$123.81 (reported Feb 17), a ~5.88% reduction in his holdings — another insider liquidity event to note. CFO Form 4
• Negative Sentiment: General Counsel Philip Mazzara sold 4,849 shares at ~$123.80 (reported Feb 17), a ~3.39% cut to his stake — part of the same round of insider sales. GC Form 4

Insider Activity at Astera Labs

In related news, CEO Jitendra Mohan sold 94,971 shares of the company’s stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the sale, the chief executive officer owned 1,452,739 shares of the company’s stock, valued at approximately $179,863,615.59. This represents a 6.14% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Michael Truett Tate sold 12,001 shares of the firm’s stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total transaction of $1,485,843.81. Following the completion of the transaction, the chief financial officer directly owned 192,083 shares of the company’s stock, valued at approximately $23,781,796.23. The trade was a 5.88% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 389,792 shares of company stock valued at $56,013,809 in the last quarter. 12.50% of the stock is currently owned by company insiders.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.